Lifecore Biomedical Services Capacity Update October 2024: Fill/Finish

Join Darren Hieber, SVP of Corporate Development, to explore how our injectables CDMO capabilities could be the perfect home for your next molecule. With extensive capacity supported by a highly skilled team, we bring expertise in formulations ranging from straightforward solutions to complex and viscous products.

With over 20 commercialized products, a strong 40+ year regulatory track record, and expanded isolator filler capacity, we are prepared to demonstrate how our services can drive your project forward and help bring impactful therapies to patients.